St.shine Optical (1565) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 精華

St.shine Optical (1565) reported revenue of NT$281.4 million for Oct 2026, -11.5% year on year and -7.0% from the previous month. Revenue for Jan–Oct 2026 was NT$2.97 billion (-15.0% year on year).

In Oct 2026, it ranked No. 35 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$413.1 million24/10Nov 2024 NT$395.6 millionDec 2024 NT$421.2 millionJan 2025 NT$331.1 millionFeb 2025 NT$403 million25/02Mar 2025 NT$376.9 millionApr 2025 NT$364.4 millionMay 2025 NT$330.5 millionJun 2025 NT$362.6 million25/06Jul 2025 NT$337.8 millionAug 2025 NT$345.1 millionSep 2025 NT$323 millionOct 2025 NT$317.8 million25/10Nov 2025 NT$301.4 millionDec 2025 NT$323.3 millionJan 2026 NT$311 millionFeb 2026 NT$283.5 million26/02Mar 2026 NT$305.1 millionApr 2026 NT$303.8 millionMay 2026 NT$275.3 millionJun 2026 NT$301.7 million26/06Jul 2026 NT$303.4 millionAug 2026 NT$302.1 millionSep 2026 NT$302.6 millionOct 2026 NT$281.4 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$281.4 million-11.5%-7.0%
Sep 2026NT$302.6 million-6.3%+0.1%
Aug 2026NT$302.1 million-12.5%-0.4%
Jul 2026NT$303.4 million-10.2%+0.6%
Jun 2026NT$301.7 million-16.8%+9.6%
May 2026NT$275.3 million-16.7%-9.4%
Apr 2026NT$303.8 million-16.6%-0.4%
Mar 2026NT$305.1 million-19.0%+7.6%
Feb 2026NT$283.5 million-29.7%-8.8%
Jan 2026NT$311 million-6.1%-3.8%
Dec 2025NT$323.3 million-23.3%+7.2%
Nov 2025NT$301.4 million-23.8%-5.1%
Oct 2025NT$317.8 million-23.1%-1.6%
Sep 2025NT$323 million-22.1%-6.4%
Aug 2025NT$345.1 million-14.2%+2.2%
Jul 2025NT$337.8 million-17.0%-6.8%
Jun 2025NT$362.6 million+12.2%+9.7%
May 2025NT$330.5 million-3.7%-9.3%
Apr 2025NT$364.4 million+10.4%-3.3%
Mar 2025NT$376.9 million-0.3%-6.5%
Feb 2025NT$403 million+27.9%+21.7%
Jan 2025NT$331.1 million-18.5%-21.4%
Dec 2024NT$421.2 million+10.5%+6.5%
Nov 2024NT$395.6 million+3.7%-4.2%
Oct 2024NT$413.1 million+11.1%-0.4%

Jan–Oct 2026 cumulative: NT$2.97 billion (-15.0% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: St.shine Optical vs PEC / St.shine Optical vs Lotus Pharm / St.shine Optical vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16